📰 Segments Profiled News
Page 30 - Segments Profiled News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Segments Profiled. Real-time updates on events, politics, business and more.
February 20, 2023
The global Chloangiocarcinoma Therapeutics Market is predicted to generate a market value of US$ 800 million in 2023 and a market value of US$ 975.20 million by 2033, with a CAGR of 2% from 2023 to 2033. Changes in bile duct anatomy caused by inflammatory bowel illness, as well as exposure to certain toxins and poll...
February 17, 2023
The global Dementia Management Market is expected to garner a market value of US$ 35 Million in 2023 and is expected to accumulate a market value of US$ 75.56 Million by registering a CAGR of8% in the forecast period 2023 to 2033. The market for Dementia Management registered a CAGR of 5% in the historical period 20...
February 17, 2023
The global cryoglobulinemia treatment market is anticipated to reach a market value of US$ 496 Million in 2023 and US$ 888.26 Million by 2033, registering a CAGR of 6% during that time. The rising incidence of the condition and the availability of numerous treatments can be linked to the market growth for cryoglobul...
February 17, 2023
During the forecast period 2023 to 2033, the Low-grade Glioma therapeutics market is expected to grow at a value of 4.57% CAGR, according to Future Market Insights. By the year 2033, the global market for Low-grade Glioma therapeutics is expected to rise up to a market valuation of US$ 1515.47 Million. Growth of the...
February 17, 2023
The global Whim Syndrome Management Market is predicted to generate a market value of US$ 10 million in 2023 and a market value of US$ 17.91 million by 2033, with a CAGR of 6% from 2023 to 2033. Between 2018 and 2022, the market for Whim Syndrome Management grew at a CAGR of 4%.The Whim Syndrome Management market is...
February 16, 2023
The global next generation immunotherapies market is estimated to exceed a spectacular valuation of US$ 268.84 billion in 2033, with a compound annual growth rate (CAGR) of 7.5% projected from 2023 to 2033. The vast majority of present immunotherapies, such as checkpoint inhibitors, seek to enhance the immune system...
February 15, 2023
A recently published study by FMI expects the global Laband syndrome therapeutics market to augment at a 5.2% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 5 Billion is expected for the market.Rising awareness of rare diseases and increased attention to heredity-related problem...
February 15, 2023
According to Future Market Insights, the global pork tapeworm infection treatment is expected to grow at a CAGR of 8% between 2023 and 2033, reaching US$ 25.17 Billion in 2033. It is expected that the market will further grow as the number of test kits and devices continues to increase. It is expected that the marke...
February 13, 2023
A recently published study by FMI expects the global Aesthetic Medical Devices Market to augment at a 9.6% CAGR from 2022 to 2032. By the end of the said assessment period, a valuation of US$ 35000 Million is expected for the market. The increase may be attributed mostly to the increased development of technological...
February 13, 2023
During the forecast period 2023 to 2033, the Erythema treatment market is expected to grow at a value of 5.5% CAGR, according to Future Market Insights. By the year 2033, the global market for Erythema treatment is expected to rise up to a market valuation of US$ 184.41 Million. Growth of the market can be attribute...